RTC
NVO

Riverview Trust Company’s Novo Nordisk NVO Stock Holding History

Riverview Trust Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54K Hold
42
– – ﹤0.01% 196
2025
Q4 		$2.14K Hold
42
– – ﹤0.01% 209
2025
Q3 		$2.33K Hold
42
– – ﹤0.01% 196
2025
Q2 		$2.9K Sell
42
-42
-50% -$2.86K ﹤0.01% 213
2025
Q1 		$5.83K Hold
84
– – 0.01% 578
2024
Q4 		$7.23K Sell
84
-160
-66% -$17.3K 0.01% 585
2024
Q3 		$29.1K Hold
244
– – 0.03% 334
2024
Q2 		$34.8K Buy
+244
New +$32.3K 0.03% 282

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Riverview Trust Company's NVO Position: Q1 2026 in Review

Riverview Trust Company held its Novo Nordisk (NVO) position steady in Q1 2026 at 42 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #196.

Riverview Trust Company first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $34.8K in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Riverview Trust Company held 42 shares of Novo Nordisk worth $1.54K as of Q1 2026.
  • Riverview Trust Company left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Riverview Trust Company's portfolio in Q1 2026, its #196 holding.
  • Riverview Trust Company first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
  • Riverview Trust Company's Novo Nordisk position peaked at $34.8K in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Riverview Trust Company's 13F filing for Q1 2026, filed 1 May 2026.